Singapore markets open in 8 hours 58 minutes

Zevra Therapeutics, Inc. (ZVRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.08+0.34 (+5.04%)
At close: 04:00PM EST
7.10 +0.02 (+0.28%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.74
Open6.75
Bid7.05 x 900
Ask7.10 x 1000
Day's range6.71 - 7.10
52-week range3.89 - 7.28
Volume179,293
Avg. volume266,737
Market cap277.43M
Beta (5Y monthly)1.78
PE ratio (TTM)N/A
EPS (TTM)-1.16
Earnings date05 Mar 2024 - 11 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.25
  • GlobeNewswire

    Zevra Therapeutics to Participate at Upcoming Investor Conferences

    CELEBRATION, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, President and Chief Executive Officer of Zevra, will present at upcoming investor conferences in March 2024. Additionally, management will be available for one-on-one meetings with registered attendees at each of the conferences. Mr. McFarlane will present at the TD Cowen 44th Annual Health Care Confere

  • Zacks

    Zevra Therapeutics (ZVRA) Soars 6.6%: Is Further Upside Left in the Stock?

    Zevra Therapeutics (ZVRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • GlobeNewswire

    Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

    CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference being held virtually on Tuesday, February 13, 2024, at 9:20 a.m. ET. Additionally, members of Zevra’s management team will be available for one-on-one investor meetings with registered attendees during the conference from February